Higher Medicine Establishes Higher Therapeutics to Advance Friedreich’s Ataxia Program

Higher Medicine announces the formation of Higher Therapeutics, a wholly-owned, Delaware-based subsidiary dedicated to developing novel treatments for Friedreich’s ataxia.